IDEAYA Biosciences Inc
IDYA
ISIN null / Valor 47686107
IDEAYA Biosciences Inc
UMushroom community rating:
About company
IDEAYA Biosciences Inc. is a clinical-stage precision medicine oncology company based in South San Francisco, California. The company focuses on the discovery and development of targeted therapeutics for cancer patients, utilizing molecular diagnostics to select patient populations. IDEAYA's primary area of expertise is in synthetic lethality, a novel class of precision medicine targets. The company integrates target and biomarker discovery with the development of small molecule and protein degrader therapeutics, spanning from early discovery stages through clinical development. IDEAYA aims to address unmet needs in cancer treatment by advancing therapeutics that have the potential to be first-in-class or best-in-class.
Summarized from source with an LLMView SourceSector: TechnologyLatest Results (10.10.2025):
IDEAYA Biosciences Inc. reported its second quarter of 2025 financial results, highlighting a robust cash position to support ongoing and future operations.
Strong Cash Reserves
As of June 30, 2025, IDEAYA Biosciences Inc. held approximately $992 million in cash, cash equivalents, and marketable securities, which is anticipated to fund operations through 2029.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
2979 M
Market cap (USD)
587,586
Daily traded volume (Shares)
25.07 / 24.31
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Wesley Jefferson Yap
EQUITIES OF THE SAME SECTOR
